We have constructed a recombinant baculovirus containing cloned DNA encoding the membrane and envelope (E) proteins of 17D yellow fever vaccine virus. Spodoptera frugiperda cells infected with this recombinant baculovirus produced a 66K protein which corresponded to the estimated size of the protein encoded by the cloned inserted DNA, and a 54K protein with the same molecular size as that of the authentic 17D yellow fever virus E protein. This recombinant 54K protein was labile, producing E protein-specific breakdown products (45K to 36K). Indirect immunofluorescence, using a panel of E protein-specific monoclonal antibodies, showed that the recombinant protein was presented both inside as well as on the surface of cells and was antigenically indistinguishable from the E protein of 17D yellow fever vaccine virus.
Yellow fever (YF) virus is the prototype species of the family Flaviviridae (Westaway et al., 1985) . Despite the availability of a safe vaccine and effective mosquito control measures, the virus still causes significant health problems in Africa and tropical South America (Monath et al., 1980; Monath & Nystrom, 1984) . Determination of the entire nucleotide sequence of 17D YF vaccine virus by Rice et al. (1985) represented a milestone in yellow fever research, by accelerating molecular studies of the virus. The viral proteins, which are encoded in a single open reading frame on the 11 kb RNA genome (Rice et al., 1985) , are produced by a complex series of cotranslational and post-translational proteolytic cleavages (Chambers et al., 1990) . The envelope (E) protein is particularly important because it is broadly crossreactive antigenically and induces both neutralizing and protective immune responses (see Porterfield, 1980; Buckley & Gould, 1985; Gould et al., 1986) . We have produced a recombinant baculovirus that expresses the E protein of the 17D YF vaccine virus. Using defined monoclonal antibodies (MAbs), we have compared the antigenic and biochemical properties of the genetically engineered protein with those of the authentic viral protein.
The cDNA clone encoding the structural and NS1 proteins of 17D YF vaccine strain was kindly supplied by Dr C. M. Rice (Washington University, St Louis, Mo., U.S.A.). All subsequent molecular manipulations followed standard techniques (Sambrook et al., 1989) . The YF virus cDNA clone was digested with BanI and HindlII, to excise the fragment encoding the membrane (M) protein, E protein and the amino-terminal part of the non-structural NS1 protein [nucleotides 600 to 2578 (Rice et al., 1985) ]. The sticky ends of the restriction fragment were then filled in using the Klenow fragment of DNA polymerase I and blunt-end ligated into dephosphorylated, Sa/I-digested and Klenow fragmentrepaired, pUC4K. The YF virus cDNA insert was subsequently retrieved from pUC4K by BamHI digestion and ligated into the BamHI site of the pAcYMI transfer vector. Recombinant transfer vector with the insert in the sense orientation was selected by restriction mapping.
Spodoptera frugiperda (SO cells (106) were incubated with 1 ml foetal calf serum (FCS)-free TC100 medium just before transfection. Transfection mixture (24 14), containing 200 ng purified infectious Autographa californica nuclear polyhedrosis virus DNA, 2 ~tg transfer vector DNA and 8 ~tl of Lipofectin (BRL), was then added to the Sf cells, which were incubated at 28 °C. The supernatant medium was replaced with fresh TC100 medium containing 10% FCS 5 h later. The medium was harvested 48 h post-infection (p.i.) and the infectivity of the resultant virus was titrated on confluent monolayers of Sf cells (Matsuura et al., 1986 (Matsuura et al., , 1987 . Plaques exhibiting no evidence of occlusion bodies, as determined by transmission light microscopy, were recovered and retitrated on Sf cells to obtain recombinant 0001-0122 © 1991 SGM polyhedrin-negative virus. Following a third plaque purification, a high titre (107 to 10 s p.f.u./ml) recombinant virus stock was produced for protein analyses.
Expression of the E protein was examined by radioimmunoprecipitation (RIP) and immunoblotting (IB) of Sf cell lysate infected with recombinant baculovirus (m.o.i. of 10) using E protein-specific MAb 813 (Gould et al., 1985b) . For RIP, labelled cell lysates were prepared from both CV-1 cells infected with 17D YF virus (m.o.i. of 5) and Sf cells infected with recombinant baculovirus. Infected CV-1 cells were incubated at 37 °C with Leibovitz L15 medium containing 5% FCS. Actinomycin D (5 ~tg/ml) was added to the growth medium from 30 h p.i. until harvesting with lysis buffer (1% Triton X-100, 0.1% SDS, 600 units/ml aprotinin, 2 mM-PMSF, 10 mM-Tris-HC1 pH 8.0, 1 mM-EDTA and 100 mM-NaC1). At 42 h p.i., CV-1 cells were incubated with methionine-free and FCS-free medium for 2 h and then labelled with [35S]methionine (100 ~tCi/ml) for 4 h. Recombinant baculovirus-infected Sf cells were incubated with methionine-free and FCS-free TC100 medium 24 h p.i. for 1 h and then labelled with [35S]methionine (30 ~tCi/ml) for 3 h at 28 °C before harvesting with lysis buffer. Immune complexes formed between MAb 813 and labelled antigens were precipitated using staphylococcus protein A-Sepharose (Sigma) and washed. Proteins were resolved on a 10% SDSpolyacrylamide gel (Laemmli, 1970) and visualized by autoradiography. For IB, concentrated 17D YF virus from the supernatant of infected cells (10 ~tl) and lysed recombinant baculovirus-infected Sf cells (105) were resolved on 10% SDS-PAGE (Laemmli, 1970) under non-reducing conditions (Cane & Gould, 1989 ) and electroblotted onto nitrocellulose paper. The blot was then incubated overnight at 4 °C with MAb 813 diluted in PBS containing 5 % milk powder and 0.05 % Tween 20. The filter was subsequently incubated for 90 min at room temperature with anti-mouse Ig linked to horseradish peroxidase (Bio-Rad) and developed using diaminobenzidine and hydrogen peroxide. The antigenic properties of expressed E protein were compared by indirect immunofluoresence with the 17D and Asibi strains of YF virus using a panel of YF virus E protein-specific MAbs. Sf cells infected with recombinant baculovirus and Vero cells infected with 17D or Asibi YF virus were tested by immunofluorescence using the biotin-streptavidin method (Gould et al., 1985a) .
RIP tests on recombinant baculovirus-infected Sf cell lysates with YF virus E protein-specific MAb 813 revealed 66K and 54K protein bands which presumably corresponded to a precursor protein containing M, E and part of NS1, and the E protein respectively (Fig. 1) . The immunoprecipitated 54K band migrated at the same position as the E protein of authentic 17D YF virus. Moreover, several other smaller labelled bands (42K to 36K) were also precipitated by MAb 813 from the recombinant baculovirus-infected Sf cell lysate. By IB, the 54K protein band of 17D YF virus E protein was not demonstrated readily in the recombinant baculovirusinfected cell lysate. Instead, strong double bands of apparent MrS of 45K and 42K were observed (Fig. 2) . This is consistent with the previous report by Cane & Gould (1989) (Fig. 3) . The baculovirus expression system has been used successfully to express proteins encoded by a variety of viruses, including Japanese encephalitis (JE) (Matsuura (Gould et at., 1985 (Gould et at., , 1990 ).
(~) et al., 1989) and dengue viruses (Zhang et al., 1988) . We have demonstrated the expression of the 54K 17D YF virus E protein by preparing an appropriate recombinant baculovirus expression vector. The recombinant baculovirus-expressed 54K E protein also was cleaved properly from the polyprotein precursor by endoplasmic signalase and transported to the surface of Sf cells, as was reported similarly for the JE virus E protein expressed by recombinant baculovirus (Matsuura et al., 1989) . Since no M protein-specific MAbs were available, it was not possible to identify the M protein. However, a 66K protein precipitated by E protein-specific MAbs presumably represented the uncleaved M and E proteins, and part of the NS1 polyprotein. Smaller E protein-specific polypeptides (45K to 36K) were also identified by RIP and IB. These probably represented breakdown products of the E protein equivalent to those described previously (Gould et al., 1985b; Cane & Gould, 1989) . Thus, the 
